主要收入构成
报告期：2022-12-31
| 主营产品构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 感冒药 |
12.97% |
583.79 |
88.44% |
282.13 |
51.67% |
-4.61% |
| 抗病毒抗感染 |
19.67% |
885.67 |
3.32% |
631.96 |
28.65% |
6.37% |
| 抗肿瘤 |
3.49% |
156.97 |
86.37% |
44.82 |
71.45% |
2.27% |
| 其他（补充） |
1.19% |
53.63 |
-12.17% |
25.57 |
52.32% |
-16.13% |
| 其它 |
4.40% |
198.16 |
-- |
169.00 |
14.72% |
-- |
| 消化系统 |
6.65% |
299.63 |
0.44% |
103.86 |
65.34% |
-2.01% |
| 心脑血管 |
6.45% |
290.30 |
11.41% |
55.44 |
80.90% |
-1.53% |
| 营养补充剂 |
45.18% |
2034.47 |
36.53% |
644.55 |
68.32% |
-8.24% |
| 总计 |
4502.61 |
| 行业收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 保健品 |
5.43% |
766.12 |
867.96% |
248.12 |
67.61% |
22.02% |
| 分部间抵消 |
-- |
-291.84 |
-- |
-276.25 |
5.34% |
-- |
| 化学制剂 |
17.71% |
2497.57 |
-7.20% |
1057.67 |
57.65% |
-1.99% |
| 零售 |
10.29% |
1450.49 |
8.54% |
1128.87 |
22.17% |
-3.58% |
| 批发商业客户 |
15.14% |
2135.31 |
7.45% |
2044.49 |
4.25% |
-1.66% |
| 批发医疗客户 |
42.06% |
5930.31 |
0.99% |
5488.67 |
7.45% |
-0.62% |
| 其他 |
0.58% |
81.88 |
-0.11% |
59.58 |
27.23% |
-1.68% |
| 其他(补充) |
0.38% |
53.63 |
-12.17% |
25.57 |
52.32% |
-16.13% |
| 其它 |
2.78% |
391.43 |
148.89% |
216.38 |
44.72% |
11.18% |
| 生物制剂 |
1.09% |
153.68 |
56.44% |
43.15 |
71.92% |
4.29% |
| 原料药 |
0.02% |
2.18 |
26.85% |
2.52 |
-15.86% |
-15.27% |
| 中药 |
4.52% |
638.01 |
46.39% |
363.92 |
42.96% |
-19.95% |
| 总计 |
13808.76 |
| 地区收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 国内地区 |
99.59% |
13751.69 |
8.00% |
10373.77 |
24.56% |
1.05% |
| 国外地区 |
0.02% |
3.44 |
-57.87% |
3.35 |
2.63% |
-0.16% |
| 其他（补充） |
0.39% |
53.63 |
-12.17% |
25.57 |
52.32% |
-16.13% |
| 总计 |
13808.76 |
